Treatment Registry
TR-0013 ActiveRecorded August 2026Last verified September 2026

Compounded semaglutide

Sold by Gala Health · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
12-month plan, 48-week supply

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Advertised

“$179/mo all doses, no hidden fees”

$179Published figureCharged todayNot verified
Price sources
Enroll with Gala Health

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • August 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed as of August 2026
StatesAll 50 states
PrescriberBoth
Consult feeNot disclosed as of August 2026

Not yet checked: cancellation and membership.

Recorded from galaglp1.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. August 2026 — Prices read August 2026 by completing Gala's own intake with dummy data and stopping at the plan screen, before any payment details. The public marketing page shows only $179 a month.
  2. 2. August 2026 — The plan screen runs a countdown: "Only 24 discounts left" and "Yours is reserved for 9:57 min", above a "First shipment $120 OFF" banner. Those mechanics do not appear on any public page.
  3. 3. September 2026 — Gala prints one figure for this plan — "$179/month. All doses included. Yearly subscription." — and never says what a card is charged on the first day. The register shows $179, the number Gala publishes, rather than the $2,148 a twelve-month commitment multiplies out to.

1 further note concerns other Gala Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0013
Medication category
compounded semaglutide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). Gala Health — compounded semaglutide (TR-0013). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0013

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.